CStone Pharmaceuticals (HKSE:02616) Other Operating Expense : HK$72.1 Mil (TTM As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Other Operating Expense?

CStone Pharmaceuticals's Other Operating Expense for the six months ended in Jun. 2023 was HK$-11.4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was HK$72.1 Mil.

CStone Pharmaceuticals's quarterly Other Operating Expense declined from Jun. 2022 (HK$119.6 Mil) to Dec. 2022 (HK$83.5 Mil) and declined from Dec. 2022 (HK$83.5 Mil) to Jun. 2023 (HK$-11.4 Mil).

CStone Pharmaceuticals's annual Other Operating Expense increased from Dec. 2021 (HK$186.6 Mil) to Dec. 2022 (HK$197.5 Mil) but then declined from Dec. 2022 (HK$197.5 Mil) to Dec. 2023 (HK$118.4 Mil).

CStone Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for CStone Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Other Operating Expense Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

285.10

270.59

186.64

197.48

118.43

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial									52.45	119.62	83.52	-11.44	-

CStone Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$72.1 Mil.

CStone Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (HKSE:02616) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (HKSE:02616) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

CSPHF:USA PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (HKSE:02616) Headlines

No Headlines